BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Becton, Dickinson and Company (BDX) to Add 25 Jobs in New Jersey


3/28/2013 7:51:28 AM

Becton, Dickinson and Co. plans to increase its Wilson headcount to keep up with anticipated demand for its newly approved injectables. That’s according to our exclusive interview with Mark Sebree, the Franklin Lakes, N.J.-based president of the company’s new wholly owned subisidiary, BD Rx. He says the approval announcement isn’t just big news for BD - it’s big news for Wilson, where the facility’s headcount is increasing from 115 to 140 by the end of the year. “We’re very much in a growth mode,” he says. reiterating that the announced antihistamine approval is just one of an anticipated 20 to 30 products, and that the entire new injectables line will be developed and manufactured in Wilson. “The growth will be somewhat dependent on the market we capture.”


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES